Yonsei Med J.  2021 Apr;62(4):370-373. 10.3349/ymj.2021.62.4.370.

Ketogenic Diet in Infants with Early-Onset Epileptic Encephalopathy and SCN2A Mutation

• Tian X
• Zhang Y
• Zhang J
• Lu Y
• Men X
• Wang X

• KMID: 2514104
• DOI: http://doi.org/10.3349/ymj.2021.62.4.370

Abstract

Research has shown mutations in the voltage-gated sodium channel gene SCN2A to be associated with developmental delays and infantile seizures in patients with early-onset epileptic encephalopathies (EOEEs). Here, we report the case of an infant with a de novo SCN2A mutation with EOEE who had medically refractory seizures that improved with a ketogenic diet (KD) implemented at an age less than 2 months. On the day of his birth, the infant presented with a pattern of convulsions with dozens of episodes per day. An initial video electroencephalogram revealed poor reactivity of background activity, with multiple partial episodes starting from the right temporal region, and abnormal electrical activity in the right hemisphere. The seizures previously were not controlled with successive therapy with phenobarbital, topiramate, and levetiracetam. Genetic testing revealed the presence of a mutation in the SCN2A gene (c.4425C>G, p.Asn1475Lys). The infant’s seizures decreased significantly with a combination of KD and medication. The present case exemplifies the potential for personalized genomics in identifying the etiology of an illness. Furthermore, the KD appears to feasible in infants younger than 2 months and might elicit good responses to EOEE associated with SCN2A mutation.

Keyword

Early-onset epileptic encephalopathy; SCN2A mutation; ketogenic diet; infant; de novo mutation